• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Earthquakes take a nearly 100% profit cut from Sorin

Earthquakes take a nearly 100% profit cut from Sorin

November 1, 2012 By MassDevice staff

Sorin Group

Sorin Group (BIT:SRN) said the May earthquake in northern Italy, which damaged its plant in Mirandola, helped push its bottom line to nearly zero during the 3rd quarter.

The Italian medical device company reported profits of $260,000 (€200,000) on sales of $207.8 million (€160.4 million) for the 3 months ended Sept. 30, for a bottom-line plunge of 98.3% on a sales decline of 6.4%.

"Sorin Group estimates that the negative impact for the quarter from the manufacturing interruption of the Mirandola plant following the earthquakes of May 2012 was, respectively, around €30 million [$38.9 million] in revenue, €13 million [$16.8 million] in net profit and €5 million [$6.5 million] in cash flow. The income statement does not include yet any indemnification from the insurance policy program," according to a press release.

Sign up to get our free newsletters delivered straight to your inbox

"Despite a challenging macro-economic environment and a quarter in which we were most significantly impacted by the earthquakes, we continued to perform well with good results in our base business and the full operational recovery of the cardiopulmonary business unit," CEO André-Michel Ballester said in prepared remarks. "We are making good progress implementing our long-term growth strategy, as confirmed by the recent CalMed acquisition and Cardiosolutions investment, both closed during the quarter."

The temblors killed at least 27 people last May. The first, rated at 6.1 on the Richter scale, struck May 20, with a pair of 5.2-magnitude aftershocks following first an hour later and then 11 hours after the first quake. Another 5.8-magnitude temblor hit May 29, causing widespread damage, especially to infrastructure damaged during the first quake, and killed 20 people.

Excluding the impact of the earthquakes (and excluding the revenue impact), Sorin said adjusted net profits were $4.0 million [€3.1 million], down 88.8% compared with the same period last year.

Sorin said it expects 4th-quarter revenues of between €185 million and €190 million ($239.7 million-$246.2 million).

"The company estimates that the product segments impacted by the earthquakes would have generated, under normal conditions, additional revenues of approximately €20 million ($25.9 million)," according to the release.

For the full year, Sorin pegged the negative impact of the quakes at €65 million-€70 million ($84.2 million-$90.7 million), "substantially better than the original outlook."

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2012, Q3, Sorin Group

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy